会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Methods and compositions for treating dental structures
    • 治疗牙科结构的方法和组合物
    • US4652444A
    • 1987-03-24
    • US681565
    • 1984-12-14
    • Gerald L. Maurer
    • Gerald L. Maurer
    • A61K8/365A61Q11/00C07C51/41C07C59/265A61K7/16A61K31/28A61K31/30
    • C07C59/265A61K8/365A61Q11/00C07C51/418A61K2800/58
    • Novel methods and dental compositions for treating dental structures, such as teeth and subgingival structures, are disclosed. Uniquely, the dental compositions contain metal complexes which are characterized as having an unique aqueous proton induced dissociation property represented by a sigmoidally-shaped curve on a cartesian coordinate plot of the negative log of the metal ion concentration versus the negative log of the hydrogen ion concentration. This unique dissociation property enables the metal complexes to release therapeutic metal ions in the oral cavity for forming metal coordination complexes or salts within the dental structures. The formation of such complexes or salts within the dental structures is particularly effective and highly resistant to enzymatic degradation associated with microbial activity. Also, the metal ions of this invention are highly effective in inactivating the enzymes secreted by microbes in the oral cavity to further attenuate the disintegration process. The metal complexes of the new and vastly improved dental compositions advantageously are highly soluble yet readily dissociable at pH ranges normally encountered in the human mouth. As the active ingredient, the dental compositions contain a monometal complex of a multivalent heavy metal ion and a polyfunctional organic ligand in a ratio of about 1:1. An example of a dental composition employed is disodium monocopper(II) citrate in an amount of about 4 mg./ml., as copper, in a liquid vehicle having a pH of about 7.
    • 公开了用于治疗诸如牙齿和龈下结构之类牙科结构的新方法和牙科组合物。 独特地,牙科用组合物含有金属络合物,其特征在于具有独特的质子诱导的解离性质,由金属离子浓度的负对数相对于氢离子浓度的负对数的笛卡儿坐标图表示的乙状结构曲线 。 这种独特的解离性使得金属络合物能够在口腔中释放治疗性金属离子,以在牙科结构内形成金属配位络合物或盐。 牙科结构内这种复合物或盐的形成对于与微生物活性相关的酶降解是特别有效的。 此外,本发明的金属离子在灭活口腔中微生物分泌的酶方面是非常有效的,以进一步减弱崩解过程。 新的和大大改进的牙科组合物的金属络合物有利地是高度可溶的,但在人口通常遇到的pH范围容易解离。 作为活性成分,牙科用组合物含有约1:1的多价重金属离子和多官能有机配体的单金属络合物。 使用的牙科用组合物的一个实例是柠檬酸二钠(柠檬酸钠),其pH值约为7,液体载体中约4mg./ml,作为铜。
    • 4. 发明授权
    • Method and compositions for treating dental structures
    • 治疗牙科结构的方法和组合物
    • US4708864A
    • 1987-11-24
    • US28552
    • 1987-03-20
    • Gerald L. Maurer
    • Gerald L. Maurer
    • A61K8/365A61Q11/00C07C51/41C07C59/265A61K7/16A61K31/28A61K31/30
    • C07C59/265A61K8/365A61Q11/00C07C51/418A61K2800/58
    • Novel methods and dental compositions for treating dental structures, such as teeth and subgingival structures, are disclosed. Uniquely, the dental compositions contain metal complexes which are characterized as having a unique aqueous proton induced dissociation property represented by a sigmoidally-shaped curve on a cartesian coordinate plot of the negative log of the metal ion concentration versus the negative log of the hydrogen ion concentration. This unique dissociation property enables the metal complexes to release therapeutic metal ions in the oral cavity for forming metal coordination complexes or salts within the dental structures. The formation of such complexes or salts within the dental structures is particularly effective and highly resistant to enzymatic degradation associated with microbial activity. Also, the metal ions of this invention are highly effective in inactivating the enzyme secreted by microbes in the oral cavity to further attenuate the disintegration process. The metal complexes of the new and vastly improved dental compositions advantageously are highly soluble yet readily dissociable at pH ranges normally encountered in the human mouth. As the active ingredient, the dental compositions contain a monometal complex of a multi-valent heavy metal ion and a polyfunctional organic ligand in a ratio of about 1:1. An example of a dental composition employed is disodium monocopper (II) citrate in an amount of about 4 mg./ml., as copper, in a liquid vehicle having a pH of about 7.
    • 公开了用于治疗诸如牙齿和龈下结构之类牙科结构的新方法和牙科组合物。 独特地,牙科用组合物含有金属配合物,其特征在于具有独特的质子诱导的解离性质,由金属离子浓度的负对数相对于氢离子浓度的负对数的笛卡尔坐标图表示的乙状结构曲线 。 这种独特的解离性使得金属络合物能够在口腔中释放治疗性金属离子,以在牙科结构内形成金属配位络合物或盐。 牙科结构内这种复合物或盐的形成对于与微生物活性相关的酶降解是特别有效的。 此外,本发明的金属离子在灭活口腔中微生物分泌的酶方面是非常有效的,以进一步减弱崩解过程。 新的和大大改进的牙科组合物的金属络合物有利地是高度可溶的,但在人口通常遇到的pH范围容易解离。 作为活性成分,牙科用组合物含有比例约为1:1的多价重金属离子和多官能有机配体的单金属络合物。 使用的牙科用组合物的一个实例是柠檬酸二钠(柠檬酸钠),其pH值约为7,液体载体中约4mg./ml,作为铜。
    • 5. 发明授权
    • Nontoxic biocompatible deodorizing compositions
    • 无毒生物相容性除臭组合物
    • US06303111B1
    • 2001-10-16
    • US09328101
    • 1999-06-08
    • Gerald L. MaurerDavid Melzer
    • Gerald L. MaurerDavid Melzer
    • A61L901
    • A61L9/01A61L9/14
    • Nontoxic biocompatible deodorizing compositions are essentially free of nonbiocompatible components and comprise, by volume, from about 0.05 to about 0.5 percent of an odor elimination agent, in combination with a physiologically compatible buffering agent, a wetting agent and a polar diluent. The compositions are suitable dispensed from a spray dispenser and are adapted for reducing malodors in environments where contact of the compositions with humans or animals having compromised or reduced chemical or microbiological resistance is anticipated or not easily prevented, for example in operating rooms, intensive care units, neonatal nurseries, and additional health care facilities.
    • 无毒生物相容性除臭组合物基本上不含非相容性组分,并且体积含有约0.05%至约0.5%的除味剂,与生理上相容的缓冲剂,润湿剂和极性稀释剂组合。 组合物适合从喷雾分配器分配,并且适于在预期或不容易防止组合物与人或动物受损或减少的化学或微生物抗性的接触的环境中减少恶臭,例如在手术室,重症监护室 ,新生儿托儿所和额外的保健设施。
    • 10. 发明授权
    • Methods and compositions for treating inflammation or arthritis
    • 用于治疗炎症或关节炎的方法和组合物
    • US4680309A
    • 1987-07-14
    • US825674
    • 1986-02-03
    • Gerald L. Maurer
    • Gerald L. Maurer
    • A61K31/28A61K31/30A61K31/315C07C59/235C07C59/245C07C59/255C07C59/265A01N55/02
    • C07C59/245A61K31/28A61K31/30A61K31/315C07C59/235C07C59/255C07C59/265
    • A method of treating inflammation or arthritis with metal complexes that can traverse skin and animal cell membranes intact and effectively deliver and release metal ions in a controlled manner upon demand at the targeted inflammatory or arthritic areas containing endogenous reacting moieties which demand the metal ions. The metal complexes have an aqueous proton induced dissociation property represented by a sigmoidally-shaped curve on a cartesian coordinate plot of the negative log of the metal ion concentration versus the negative log of hydrogen ion concentration. This dissociation property enables the metal complexes to release metal ions in a controlled manner upon demand at the targeted inflammatory or arthritic areas containing endogenous reacting moieties which demand the metal ions. The metal complexes can be effectively administered either topically or subcutaneously. Upon topical application, the metal complexes are dispersed in a vehicle to provide a buffered composition to neutralize the initial acidic layer of the skin. These unique and advantageous properties permit the metal complexes to be incorporated into vehicles with an adjusted pH minimizing premature release of the metal ions prior to reaching the targeted inflammatory or arthritic areas. Further, the metal complexes can be dispersed in a greaseless cold cream vehicle formulated to avoid or minimize undesirable chemical incompatibilities. An example of a topical composition employed is disodiummonocopper(II) citrate in an amount of about 10% w/w in a water-dispersible cream base vehicle comprising an oil-in-water emulsion having a pH of about 7.0.
    • 用金属络合物治疗炎症或关节炎的方法,其可以在需要含有需要金属离子的内源性反应部分的靶向炎性或关节炎区域的情况下以受控的方式完整地穿过皮肤和动物细胞膜并有效递送和释放金属离子。 金属络合物具有质子诱导的离解性质,由金属离子浓度的负对数相对于氢离子浓度的负对数的笛卡尔坐标图上的乙状结构曲线表示。 这种解离性使得金属络合物能够在需要含有需要金属离子的内源性反应部分的靶向炎性或关节炎区域的受控方式释放金属离子。 金属络合物可以有效地局部或皮下给药。 在局部施用时,将金属络合物分散在载体中以提供缓冲的组合物以中和皮肤的初始酸性层。 这些独特和有利的性质允许金属配合物掺入车辆中,其中调节的pH最小化到达靶向的炎性或关节炎区域之前金属离子的过早释放。 此外,金属络合物可以分散在配制成避免或最小化不期望的化学不相容性的无油冷奶油车中。 使用的局部组合物的实例是在包含pH为约7.0的水包油乳液的水分散性乳膏基载体中,柠檬酸二钠(II)柠檬酸盐的量为约10%w / w。